相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Matteo Bassetti et al.
LANCET INFECTIOUS DISEASES (2021)
Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii
Jiaqi Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii
B. Luna et al.
NATURE MICROBIOLOGY (2020)
In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms
Vincent Trebosc et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant Acinetobacter Infections
Matthew C. Phillips et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019
Felix Lotsch et al.
EUROSURVEILLANCE (2020)
Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016)
Ana C. Gales et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis
Xingran Du et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2019)
Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: A systematic review and meta-analysis
Jin Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Alessandro Cassini et al.
LANCET INFECTIOUS DISEASES (2019)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Current Status and Trends of Antibacterial Resistance in China
Fupin Hu et al.
CLINICAL INFECTIOUS DISEASES (2018)
Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition
Wei Lin et al.
MOLECULAR CELL (2017)
The Accidental Orthodoxy of Drs. Mueller and Hinton
Victor Nizet
EBIOMEDICINE (2017)
Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens
Leo Lin et al.
EBIOMEDICINE (2015)
X-ray Crystal Structures of the Escherichia coli RNA Polymerase in Complex with Benzoxazinorifamycins
Vadim Molodtsov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation
Soumaya Zlitni et al.
NATURE CHEMICAL BIOLOGY (2013)
Identification and Characterization of an Outer Membrane Receptor Gene in Acinetobacter baumannii Required for Utilization of Desferricoprogen, Rhodotorulic Acid, and Desferrioxamine B as Xenosiderophores
Tatsuya Funahashi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Increased Susceptibility of Pseudomonas aeruginosa to Macrolides and Ketolides in Eukaryotic Cell Culture Media and Biological Fluids Due to Decreased Expression of oprM and Increased Outer-Membrane Permeability
Julien M. Buyck et al.
CLINICAL INFECTIOUS DISEASES (2012)
Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
Maria Giannouli et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
TonB-Dependent Transporters: Regulation, Structure, and Function
Nicholas Noinaj et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010 (2010)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Rifamycins do not function by allosteric modulation of binding of Mg2+ to the RNA polymerase active center
Andrey Feklistov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects
Susan L. Ford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins
I Artsimovitch et al.
CELL (2005)
Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-β-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000
ETS Houang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Active transport of an antibiotic rifamycin derivative by the outer-membrane protein FhuA
AD Ferguson et al.
STRUCTURE (2001)
Structural mechanism for rifampicin inhibition of bacterial RNA polymerase
EA Campbell et al.
CELL (2001)
分享论文
